18-Sep-2024
Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts
Business Wire (Tue, 17-Sep 10:00 AM ET)
Pfizer (PFE) Receives a Buy from Jefferies
TipRanks (Tue, 17-Sep 8:16 AM ET)
Intel, Microsoft, Meta Platforms, Pfizer, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga (Mon, 16-Sep 10:50 PM ET)
Benzinga (Mon, 16-Sep 11:18 AM ET)
Puma Biotechnology rises on appeal of AstraZeneca Tagrisso patent dispute
Seeking Alpha News (Mon, 16-Sep 10:05 AM ET)
Do queasy side effects mean the end of weight-loss drug stock hype?
Seeking Alpha News (Sun, 15-Sep 10:07 AM ET)
J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report
Seeking Alpha News (Sat, 14-Sep 3:37 PM ET)
Pfizer therapy succeeds in mid-stage trial for cancer-related weight loss
Seeking Alpha News (Sat, 14-Sep 9:56 AM ET)
Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia
Business Wire (Sat, 14-Sep 8:45 AM ET)
Business Wire (Sat, 14-Sep 4:15 AM ET)
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Pfizer trades on the NYSE stock market under the symbol PFE.
As of September 18, 2024, PFE stock price declined to $29.75 with 23,040,051 million shares trading.
PFE has a beta of 0.19, meaning it tends to be less sensitive to market movements. PFE has a correlation of 0.01 to the broad based SPY ETF.
PFE has a market cap of $168.58 billion. This is considered a Large Cap stock.
Last quarter Pfizer reported $13 billion in Revenue and $.60 earnings per share. This beat revenue expectation by $263 million and exceeded earnings estimates by $.14.
In the last 3 years, PFE stock traded as high as $61.71 and as low as $25.20.
The top ETF exchange traded funds that PFE belongs to (by Net Assets): VTI, VOO, SCHD, SPY, IVV.
PFE stock has underperformed the market in the last year with a return of -7.8%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PFE shares. However, PFE has outperformed the market in the last 3 month and 2 week periods, returning +11.8% and +5.1%, while SPY returned +2.9% and +1.7%, respectively. This indicates PFE has been having a stronger performance recently.
PFE support price is $29.45 and resistance is $30.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PFE stock will trade within this expected range on the day.